Novolin 70/30 100 [iU]/mL

Novolin 70/30 100 [iU]/mL is a human insulin suspension injection used for managing blood sugar levels in diabetes. This pre-mixed insulin combines rapid-acting and intermediate-acting insulin for flexible dosing.

Novolin 70/30 100 [iU]/mL is primarily used for controlling blood glucose levels in individuals with diabetes. It is often prescribed for those who require both rapid-acting and intermediate-acting insulin effects. This medication is typically administered subcutaneously and is designed to mimic the body's natural insulin response to meals and between meals.

Common effects of Novolin 70/30 100 [iU]/mL may include localized reactions at the injection site, such as redness or itching. Some users may experience hypoglycemia, characterized by symptoms like sweating, dizziness, or hunger. These effects can vary among individuals and should be monitored closely.

Novolin 70/30 100 [iU]/mL should be stored properly to maintain its effectiveness. It is important to follow the storage instructions provided, typically keeping it refrigerated and protecting it from light. Always check the expiration date before use and dispose of any expired or unused medication safely.

Novolin 70/30 100 [iU]/mL may interact with other medications, including oral hypoglycemic agents, beta-blockers, and alcohol. It is advisable to consult with a healthcare provider before combining this insulin with other substances to avoid potential adverse effects.